PLoS ONE · 2010 · 40 citations · 38 references
Life SciencesMolecular BiologyPathologyProteomicsSignal TransductionTumor MicroenvironmentCancer ProteomicsClinical ProteomicsFunctional ProteomicsMass Spectrometry-based ProteomicsProteomic BiomarkersProteomic ProfilingCancer Proteome ProfilingDiagnostic ProteomicsInfiltrationLocal Tissue InfiltrationProtein Expression ProfilingTissue ProteomicsTumor Proteome ProfilingTumor Proteomics
BACKGROUND: Tissue invasion or tissue infiltration are clinical behaviors of a poor-prognosis subset of meningiomas. We carried out proteomic analyses of tissue extracts to discover new markers to accurately distinguish between infiltrative and noninfiltrative meningiomas. METHODOLOGY/PRINCIPAL FINDINGS: Protein lysates of 64 different tissue samples (including two brain-invasive and 32 infiltrative tumors) were submitted to SELDI-TOF mass spectrometric analysis. Mass profiles were used to build up both unsupervised and supervised hierarchical clustering. One marker was found at high levels in noninvasive and noninfiltrative tumors and appeared to be a discriminative marker for clustering infiltrative and/or invasive meningiomas versus noninvasive meningiomas in two distinct subsets. Sensitivity and specificity were 86.7% and 100%, respectively. This marker was purified and identified as a multiphosphorylated form of vimentin, a cytoskeletal protein expressed in meningiomas. CONCLUSIONS/SIGNIFICANCE: Specific forms of vimentin can be surrogate molecular indicators of the invasive/infiltrative phenotype in tumors.
38
Zhen Zhang, Robert C. Bast, Yinhua Yu et al. · Cancer Research · 2004 · 949 citations · Full text
Medicine, Gynecology, Oncology +17
Arie Perry, Bernd W. Scheithauer, Scott L. Stafford et al. · Cancer · 1999 · 517 citations · Full text
Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin
Erik R Vossenaar, N. Després, Elvy Lapointe et al. · Arthritis Research & Therapy · 2004 · 462 citations · Full text
Life Sciences, Immunology, Pathology +16